
|Videos|February 14, 2022
Why saw palmetto should not be overlooked in treatment of LUTS
Author(s)Urology Times staff
“I think it's important for urologists and physicians to have an open mind in regard to complementary approaches to the treatment of BPH-related LUTS in men,” says J. Curtis Nickel, MD, FRCSC.
Advertisement
In this video, J. Curtis Nickel, MD, FRCSC, discusses future research on saw palmetto and why he thinks there is enough evidence to support urologists prescribing this medication to patients suffering from lower urinary tract symptoms secondary to benign prostatic hyperplasia. Nickel is a professor of urology at Queen’s University, and a research chair in urologic pain and inflammation at Kingston Health Sciences Centre, Kingston, Ontario, Canada.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Unmet needs and emerging solutions in MRI-guided prostate cancer care
2
HHS requests testosterone therapy label updates, citing new safety data
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
5











